Related Experiment Videos
Familial Mediterranean fever-related spondyloarthropathy
P Borman1, F Gökoğlu, O Taşbaş
1Department of Physical Medicine and Rehabilitation, Ministry of Health Ankara Education and Research Hospital, Ankara, Turkey.
Abstract:
Familial Mediterranean fever (FMF) is an autosomal recessively-transmitted disease characterised by attacks of fever and serositis. Articular involvement is the second most common manifestation following abdominal pain. Patients with FMF are considered to have an increased risk of sacroiliitis, while the association of such abnormalities with FMF has not been accepted uniformly. We report two cases of FMF with accompanying seronegative spondyloarthropathy, a 18-year-old boy and a 29-year-old man, and review the literature for FMF-related seronegative spondyloarthropathy.
Insights
Familial Mediterranean fever (FMF) patients may have a higher risk of developing seronegative spondyloarthropathy. This report details two such cases and reviews existing literature on this association.
Area of Science:
- Rheumatology
- Genetics
- Internal Medicine
Background:
- Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder.
- FMF presents with recurrent fever and serositis; articular involvement is common.
- The link between FMF and sacroiliitis, a form of spondyloarthropathy, remains debated.
Observation:
- Two cases of FMF with co-occurring seronegative spondyloarthropathy are presented.
- The patients were an 18-year-old male and a 29-year-old male.
- Literature review was conducted to explore FMF-related seronegative spondyloarthropathy.
Findings:
- The cases suggest a potential association between FMF and seronegative spondyloarthropathy.
- Further research is needed to confirm the prevalence and mechanisms of this association.
- Understanding this link may improve diagnostic and treatment strategies for FMF patients.
Implications:
- Recognizing this association could lead to earlier diagnosis of spondyloarthropathy in FMF patients.
- This may prompt the development of targeted therapies for joint manifestations in FMF.
- Enhanced understanding of FMF pathophysiology may emerge from studying these comorbidities.
Related Concept Videos
Rocky Mountain Spotted Fever
Rheumatic Heart Disease I: Introduction
Multiple Sclerosis l: Introduction
Fungal Phylum Microsporidia
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests